ATSE:BIOSK

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Unibios Holdings S.A., through its subsidiaries, develops and installs water treatment systems in Europe. More Details


Snowflake Analysis

Mediocre balance sheet with acceptable track record.

Share Price & News

How has Unibios Holdings's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: BIOSK has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

-8.7%

BIOSK

0.2%

GR Machinery

3.6%

GR Market


1 Year Return

-30.7%

BIOSK

9.1%

GR Machinery

-21.0%

GR Market

Return vs Industry: BIOSK underperformed the Greek Machinery industry which returned 9.1% over the past year.

Return vs Market: BIOSK underperformed the Greek Market which returned -21% over the past year.


Shareholder returns

BIOSKIndustryMarket
7 Day-8.7%0.2%3.6%
30 Day-7.7%2.9%2.6%
90 Day-14.2%9.8%0.01%
1 Year-30.7%-30.7%12.3%9.1%-17.9%-21.0%
3 Year-52.9%-60.0%7.9%-3.3%-1.6%-10.7%
5 Year-47.9%-55.8%79.1%52.5%-17.6%-26.0%

Price Volatility Vs. Market

How volatile is Unibios Holdings's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Unibios Holdings undervalued compared to its fair value and its price relative to the market?

16.05x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate BIOSK's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate BIOSK's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: BIOSK is good value based on its PE Ratio (16.1x) compared to the XE Machinery industry average (22.1x).

PE vs Market: BIOSK is poor value based on its PE Ratio (16.1x) compared to the Greek market (13.6x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate BIOSK's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: BIOSK is good value based on its PB Ratio (0.3x) compared to the XE Machinery industry average (1.5x).


Next Steps

Future Growth

How is Unibios Holdings forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

24.2%

Forecasted Capital Goods industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Unibios Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Unibios Holdings performed over the past 5 years?

15.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: BIOSK has high quality earnings.

Growing Profit Margin: BIOSK became profitable in the past.


Past Earnings Growth Analysis

Earnings Trend: BIOSK has become profitable over the past 5 years, growing earnings by 15.3% per year.

Accelerating Growth: BIOSK has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: BIOSK has become profitable in the last year, making it difficult to compare its past year earnings growth to the Machinery industry (-23.3%).


Return on Equity

High ROE: BIOSK's Return on Equity (0.8%) is considered low.


Next Steps

Financial Health

How is Unibios Holdings's financial position?


Financial Position Analysis

Short Term Liabilities: BIOSK's short term assets (€7.2M) exceed its short term liabilities (€6.0M).

Long Term Liabilities: BIOSK's short term assets (€7.2M) exceed its long term liabilities (€3.9M).


Debt to Equity History and Analysis

Debt Level: BIOSK's debt to equity ratio (18.7%) is considered satisfactory.

Reducing Debt: BIOSK's debt to equity ratio has increased from 8.3% to 18.7% over the past 5 years.

Debt Coverage: BIOSK's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: BIOSK's interest payments on its debt are not well covered by EBIT (1.6x coverage).


Balance Sheet


Next Steps

Dividend

What is Unibios Holdings's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate BIOSK's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate BIOSK's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if BIOSK's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if BIOSK's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of BIOSK's dividend in 3 years as they are not forecast to pay a notable one for the Greek market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

Nik Mavrikios

no data

Tenure

Mr. Orfeas Nikolau Mavrikios, also known as Nik, serves as Chief Executive Officer, Vice Chairman and Managing Director at Unibios Holdings S.A. He holds Bachelor's degree in Economics at Hamilton College ...


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 402.6%.


Top Shareholders

Company Information

Unibios Holdings S.A.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Unibios Holdings S.A.
  • Ticker: BIOSK
  • Exchange: ATSE
  • Founded: 1940
  • Industry: Industrial Machinery
  • Sector: Capital Goods
  • Market Cap: €3.761m
  • Shares outstanding: 15.60m
  • Website: https://www.unibios.gr

Location

  • Unibios Holdings S.A.
  • 1st and 18th Street
  • Ano Liosia
  • 133 41
  • Greece

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
BIOSKATSE (The Athens Stock Exchange)YesOrdinary SharesGREURJul 1993

Biography

Unibios Holdings S.A., through its subsidiaries, develops and installs water treatment systems in Europe. It also offers products and systems for the heating and air conditioning of buildings. Unibios Hold ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/09/18 04:15
End of Day Share Price2020/09/17 00:00
Earnings2019/12/31
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.